The invention relates to N-phenyl-2-pyrimidine-amine derivatives of formula I ##STR00001## wherein the substituents are defined as indicated in the description, to processes for the preparation thereof, to medicaments comprising those compounds, and to the use thereof in the preparation of pharmaceutical compositions for the therapeutic treatment of warm-blooded animals, including humans.